GO
Loading...

Enter multiple symbols separated by commas

Health Care Equipment and Supplies Health Care Supplies

More

  • Henry Schein's healthy results Tuesday, 6 Aug 2013 | 2:48 PM ET
    Henry Schein's healthy results

    Henry Schein is the world's largest health care products and services company for doctors, dentists, and vets, and the stock has been on a tear. Stanley Bergman, Henry Schein chairman and CEO, shares where he sees dental and health care headed.

  • J&J beats expectations as drugs, devices deliver Tuesday, 16 Jul 2013 | 7:50 AM ET

    Johnson & Johnson reported higher-than-expected earnings as strong sales of prescription drugs and medical devices more than offset anemic growth of its consumer products.

  • Plan-B for All—No Age Limits on Morning-After Pill Tuesday, 11 Jun 2013 | 10:17 AM ET

    Obama administration to scrap age restrictions on the sale of morning-after pills, making the emergency contraception available to women and girls of any age without a prescription.

  • Bristol and Merck Shares Surge on Cancer Drug News Monday, 3 Jun 2013 | 3:32 PM ET

    Bristol-Myers Squibb and Merck stocks climbed higher Monday as analysts said billions stood to be made from treatment breakthroughs.

  • US Healthcare

    Keith Smith, Co-founder, Managing Partner at the Surgery Center of Oklahoma says that all funds are channeled to patient care, helping his team deliver quality healthcare and low costs.

  • Johnson & Johnson's Stock Looks Too Healthy Wednesday, 1 May 2013 | 3:02 PM ET

    Johnson & Johnson's stock has gained 22 percent on the year and trades at a higher P/E ratio than its competitors. It is not a good buy now, but a great hold, TheStreet.com says.

  • Hospitals See Surge of Weapons in War on 'Superbugs' Monday, 29 Apr 2013 | 8:24 AM ET
    Health care insurance

    The rise of "superbugs," and pressure from the government and insurers, is driving hospitals to try all sorts of new approaches to stop their spread.

  • J&J Tops Estimates on Newer Medicine Growth Tuesday, 16 Apr 2013 | 8:16 AM ET
    Johnson & Johnson products

    The pharmaceutical and medical devices company reported quarterly earnings and revenue Tuesday that exceeded Wall Street's expectations as growth of newer medicines for cancer, hepatitis C and blood clots offset declining sales of its treatments for heartburn and attention deficit disorder.

  • Entrepreneurs Capitalizing on Legalization of Marijuana Thursday, 21 Mar 2013 | 6:23 AM ET
    Entrepreneurs Capitalizing on Legalization of Marijuana

    Roger Parloff, Fortune senior editor, says businesses are sprouting in states like Colorado and Washington, where selling cannabis is now legal.

  • Obamacare Wellness Programs Could Raise Health Costs Thursday, 21 Feb 2013 | 12:31 PM ET

    If you smoke, you might have to pay thousands extra for employee-based health insurance under Obamacare starting next year.

  • First on CNBC: Cochlear Earnings Monday, 4 Feb 2013 | 9:35 PM ET
    First on CNBC: Cochlear Earnings

    On a First on CNBC interview, Cochlear CEO Chris Roberts tells CashFlow about his company's products and plans for global expansion.

  • J&J Knew About Widespread Hip Implant Failures: Audit Wednesday, 23 Jan 2013 | 9:52 AM ET
    A Smart Bet on Johnson & Johnson?

    An internal analysis conducted by Johnson & Johnson in 2011 estimated that the all-metal device would fail within five years in nearly 40 percent of patients who received it, newly disclosed court records show.

  • Pfizer Unit IPO Carries a Huge Price Tag Friday, 18 Jan 2013 | 8:17 AM ET
    Pfizer Profit Drops on Loss of Lipitor Exclusivity

    Pfizer's unit Zoetis plans to sell 86.1 million shares at between $22 and $25 each in an initial public offering.

  • Major Flu Outbreak Could Slow US Economy Further Thursday, 10 Jan 2013 | 12:00 AM ET

    One of the worst flu seasons in a decade is putting further strains on an already sluggish U.S. economy as companies get slammed with increased health care costs and lower productivity from widespread worker absences.

  • Big Pharma Bets on Obesity Drug Binge Thursday, 27 Dec 2012 | 2:18 AM ET

    As Christmas overeating gives way to under-fulfilled new year diets, the pharmaceutical industry's appetite has been whetted for a fresh surge in business.

  • Health Care Needs More Entrepreneurs and Innovation: Google Ventures Head

    The managing partner of Google's venture capital, Bill Maris,  says under-investment in health sciences is short-sighted.

  • DNA

    The goal is to enable physicians and pharmaceutical companies to use complex genetic data to tailor treatment on an individual basis, according to Mike Pellini, CEO of Foundation Medical.

  • Fungal Meningitis Death Toll Reaches 8 Tuesday, 9 Oct 2012 | 1:22 PM ET
    Fungal Meningitis Death Toll Reaches 8

    According to the CDC, the death toll has now reached 8 from a contaminated steroid used to treat back pain that came from a Massachusetts Compounding pharmacy. The next update from the CDC will be at 2PM EST today.

  • Qualcomm's Jacobs: Mighty Payoff to Mobile Medicine Tuesday, 9 Oct 2012 | 10:53 AM ET
    Paul_E._Jacobs-200.jpg

    Qualcomm's CEO Paul Jacobs says the smart phone will become a focal point for wirelessly connecting medical devices, diagnostics and sensors, and providing near real-time information.

  • Stakes for Alzheimer's Cure Rise as America Ages Monday, 8 Oct 2012 | 2:56 PM ET
    Man with Alzheimer

    The aging of America is taking a toll on the health care system. By 2050, the cost of treating Alzheimer's patients will hit $1 trillion a year.